• Why Aurora Breast MRI
• Product Overview
• Medical Education
  • Resources & Links
  • Clinical Presentations
• SpiralRODEO™ Sample Images
• Advisory Board
• Clinical Case Studies
• Testimonials

• Reimbursement
• Siting Requirements
• Company Overview
• Aurora News & Events
• Aurora Locations
• Contact Us

Continuing Medical Education CME

Aurora Imaging Technology, Inc. is committed to providing continuing medical education (CME) programs and other valuable educational programs and services for healthcare professionals.

Recommended Breast MRI References:

Leach MO, Boggis CRM, Dixon AK, et al. Screening with Magnetic Resonance Imaging and Mammography of a UK Population at High Familial Risk of Breast Cancer: A Prospective Multicentre Cohort Study (MARIBS).Lancet 2005; 365:1769-1778.

Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic Resonance Imaging of the Breast Prior to Biopsy.JAMA 2004; 292(22):2735-2742.

Lehman CD, Schnall MD, Kuhl CK, Harms SE. Report of the Working Groups on Breast MRI: Report of the High-Risk Screening Group. Breast J. 2004; 10(S5):S9-S12.

Harms SE, Rabinovitch R, Julian TB, Rafferty E, Masood S, Weatherall P. Report of the Working Groups on Breast MRI: Report of the Breast Cancer Staging Group.
Breast J. 2004; 10(S5):S3-S8.

Klimberg VS, Henry-Tillman R, Julian TB, Robinson D, Smith DM, Mark J, Schubert T, Oslan A, Gibson RM, Harms SE. Report of the Working Groups on Breast MRI: Report of the Biopsy and Intervention Working Group. Breast J. 2004; 10(S5):S13-S16.

Kriege M, Brekelmans CTM, Boetes C, et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. N Engl J Med 2004;351:427-437.

Liberman L. Breast Cancer Screening with MRI – What are the Data for Patients at High Risk? N Engl J Med 2004;351:497-500.

Warner E., Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 Mutation Carriers with Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination. JAMA 2004;292(11):1317-1325.

Robson M, Offit K. Breast MRI for Women with Hereditary Cancer Risk. JAMA 2004;292(11):1368-1370.

Harms SE. Breast Magnetic Resonance Imaging. Semin Ultrasound CT MR. 1998;19(1):104-20.

Soderstrom CE, Harms SE, Farrell RS, Jr., Pruneda JM, Flamig DP. Detection with MR Imaging of Residual Tumor in the Breast Soon After Surgery. AJR Am J Roentgenol. 1997;168(2):485-8.

Harms SE. MRI in Breast Cancer Diagnosis and Treatment. Curr Probl Diagn Radiol. 1996;25(6):193-215.

Rodenko GN, Harms SE, Pruneda JM, et al. MR Imaging in the Management before Surgery of Lobular Carcinoma of the Breast: Correlation with Pathology. AJR Am J Roentgenol. 1996;167(6):1415-9.

Soderstrom CE, Harms SE, Copit DS, Evans WP, Krakos PA, Farrell RS, Flamig DP. 3D RODEO Breast MRI of Lesions Containing Ductal Carcinoma in Situ. Radiology 1996; 201:427

Abraham DC, Jones RC, Jones SE, et al. Evaluation of Neoadjuvant Chemotherapeutic Response of Locally Advanced Breast Cancer by Magnetic Resonance Imaging. Cancer 1996;78(1):91-100.

Harms SE, Jensen RA, Meiches MD, Flamig DP, Evans WP. Silicone-Suppressed 3D MRI of the Breast Using Rotating Delivery of Off-Resonance Excitation. J Comput Assist Tomogr. 1995;19(3):394-9.

Harms SE, Flamig DP, Hesley KL, et al. MR Imaging of the Breast with Rotating Delivery of Excitation Off Resonance: Clinical Experience with Pathologic Correlation. Radiology 1993; 187(2):493-501.

Harms SE, Flamig DP, Hesley KL et al. Fat-Suppressed Three-Dimensional MR Imaging of the Breast. RadioGraphics 1993; 13:247-267.